Skip to search.
 TSX Up 0.40% TSX Ventures Down 1.68%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
40.24 Up 0.65(1.64%) May 27, 4:00PM EDT
|After Hours : 40.25 Up 0.01 (0.02%) May 27, 4:25PM EDT
Prev Close:39.59
Open:39.65
Bid:36.65 x 100
Ask:42.00 x 1500
1y Target Est:42.62
Beta:1.93726
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:39.18 - 40.43
52wk Range:26.02 - 52.33
Volume:755,807
Avg Vol (3m):1,063,440
Market Cap:5.64B
P/E (ttm):N/A
EPS (ttm):-0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGENUp 1.64%5.64B
IMGNUp 0.18%492.86M
PFEUp 0.52%209.90B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.09
Quarterly EPS Est (Jun-16) :-0.31
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-2.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback